Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1989 2
1995 1
1999 2
2000 2
2001 3
2003 1
2005 3
2006 4
2007 5
2008 4
2009 4
2010 6
2011 7
2012 9
2013 6
2014 16
2015 13
2016 15
2017 4
2018 8
2019 5
2020 5
2021 12
2022 21
2023 10

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Improving clinical trial outcomes in amyotrophic lateral sclerosis.
Kiernan MC, Vucic S, Talbot K, McDermott CJ, Hardiman O, Shefner JM, Al-Chalabi A, Huynh W, Cudkowicz M, Talman P, Van den Berg LH, Dharmadasa T, Wicks P, Reilly C, Turner MR. Kiernan MC, et al. Among authors: wicks p. Nat Rev Neurol. 2021 Feb;17(2):104-118. doi: 10.1038/s41582-020-00434-z. Epub 2020 Dec 18. Nat Rev Neurol. 2021. PMID: 33340024 Free PMC article. Review.
ALSUntangled #64: butyrates.
Sun Y, Bedlack R, Armon C, Beauchamp M, Bertorini T, Bowser R, Bromberg M, Caress J, Carter G, Crayle J, Cudkowicz ME, Glass JD, Jackson C, Lund I, Martin S, Paganoni S, Pattee G, Ratner D, Salmon K, Wicks P. Sun Y, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):638-643. doi: 10.1080/21678421.2022.2045323. Epub 2022 Feb 28. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 35225121 Review.
ALSUntangled #67: rituximab.
Li X, Armon C, Barkhaus P, Barnes B, Benatar M, Bertorini T, Bromberg M, Carter GT, Crayle J, Cudkowicz M, Dimachkie M, Feldman EL, Glass J, Goslinga J, Heiman-Patterson T, Jhooty S, Lichtenstein R, Lund I, Mcdermott C, Pattee G, Pierce K, Ratner D, Salmon K, Wicks P, Bedlack R. Li X, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Sep 15:1-4. doi: 10.1080/21678421.2022.2122845. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 36106861 Review.
Patient, study thyself.
Wicks P. Wicks P. BMC Med. 2018 Nov 23;16(1):217. doi: 10.1186/s12916-018-1216-2. BMC Med. 2018. PMID: 30470218 Free PMC article.
ALSUntangled #66: antimycobacterial antibiotics.
Pierce ES, Barkhaus P, Beauchamp M, Bromberg M, Carter GT, Goslinga J, Greeley D, Kihuwa-Mani S, Levitsky G, Lund I, McDermott C, Pattee G, Pierce K, Polak M, Ratner D, Wicks P, Bedlack R. Pierce ES, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug 1:1-5. doi: 10.1080/21678421.2022.2104650. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 35913017 Review.
ALSUntangled #63: ketogenic diets.
Bedlack R, Barkhaus PE, Barnes B, Beauchamp M, Bertorini T, Bromberg MB, Carter GT, Chaudry V, Cudkowicz M, Jackson C, Levitsky G, Lund I, McDermott C, Novella S, Olby N, Ostrow L, Pattee GL, Heiman-Patterson T, Ratner D, Salmon K, Steves S, Terrelonge M, Wicks P, Wills AM. Bedlack R, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):159-163. doi: 10.1080/21678421.2021.1990346. Epub 2021 Oct 14. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 34645313 Review.
ALSUntangled #65: glucocorticoid corticosteroids.
Goslinga JA, Terrelonge M Jr, Bedlack R, Barkhaus P, Barnes B, Bertorini T, Bromberg M, Carter G, Chen A, Crayle J, Dimachkie M, Jiang L, Levitsky G, Lund I, Martin S, Mcdermott C, Pattee G, Pierce K, Ratner D, Slachtova L, Sun Y, Wicks P. Goslinga JA, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):351-357. doi: 10.1080/21678421.2022.2099746. Epub 2022 Aug 23. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35997522 Review.
ALSUntangled #60: light therapy.
Bedlack R, Barkhaus P, Barnes B, Bereman M, Bertorini T, Carter G, Crayle J, Kihuwa-Mani S, Bowser R, Kittrell P, McDermott C, Pattee G, Salmon K, Wicks P. Bedlack R, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2022 May;23(3-4):315-319. doi: 10.1080/21678421.2021.1883668. Epub 2021 Mar 8. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 33683159 Review.
ALSUntangled 59: Tamoxifen.
Bedlack R, Kihuwa-Mani S, Barkhaus PE, Bereman M, Caress JB, Crayle J, Pattee GL, Heiman Patterson T, Wicks P, Zach N, Carter GT, Salmon K. Bedlack R, et al. Among authors: wicks p. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):595-598. doi: 10.1080/21678421.2021.1876731. Epub 2021 Jan 21. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33474997
Patients' roles and rights in research.
Wicks P, Richards T, Denegri S, Godlee F. Wicks P, et al. BMJ. 2018 Jul 25;362:k3193. doi: 10.1136/bmj.k3193. BMJ. 2018. PMID: 30045909 No abstract available.
152 results